Medical Therapy of Heart Failure with Reduced Ejection Fraction—A Call for Comparative Research

by Gad Cotter, Beth A. Davison, Alexandre Mebazaa, Koji Takagi, Maria Novosadova, Yonathan Freund, Alain Cohen-Solal
Published 2021-04-01

Noninvasive measure of treatment response in non‐alcoholic steatohepatitis: Insights from EMMINENCE and meta‐analysis

by Beth A Davison, Christopher Edwards, Rohit Loomba, Stephen A Harrison, Gad Cotter, Naim Alkhouri, Gary G Koch, Howard C Dittrich
Published 2021-07-01

N‐terminal pro BNP and galectin‐3 are prognostic biomarkers of acute heart failure in sub‐Saharan Africa: lessons from the BAHEF trial

by Mahmoud U. Sani, Albertino Damasceno, Beth A. Davison, Gad Cotter, Bongani M. Mayosi, Christopher Edwards, Feriel Azibani, Tasneem Adam, Gulnaze Arif, Neusa Jessen, Karen Sliwa
Published 2021-02-01

Hepatorenal dysfunction identifies high‐risk patients with acute heart failure: insights from the RELAX‐AHF trial

by Jan Biegus, Biniyam Demissei, Douwe Postmus, Gad Cotter, Beth A. Davison, G. Michael Felker, Gerasimos Filippatos, Claudio Gimpelewicz, Barry Greenberg, Marco Metra, Thomas Severin, John R. Teerlink, Adriaan A. Voors, Piotr Ponikowski
Published 2019-12-01

Cardiopoietic stem cell therapy in ischaemic heart failure: long‐term clinical outcomes

by Jozef Bartunek, Andre Terzic, Beth A. Davison, Atta Behfar, Ricardo Sanz‐Ruiz, Wojciech Wojakowski, Warren Sherman, Guy R. Heyndrickx, Marco Metra, Gerasimos S. Filippatos, Scott A. Waldman, John R. Teerlink, Timothy D. Henry, Bernard J. Gersh, Roger Hajjar, Michal Tendera, Stefanie Senger, Gad Cotter, Thomas J. Povsic, William Wijns, for the CHART Program
Published 2020-12-01